Total Credits: 1 including 1 AOA Category 1-A Credit(s)
Sudden cardiac death (SCD) in a young athlete is an infrequent yet devastating event. Clinicians need to know the most current protocols for pre-athletic participation screening which are necessary to refine the detection of silent cardiovascular diseases that predispose young individuals to sudden cardiac death.
At the conclusion of this session, the participant should be able to:
- Utilize ECG in routine screening of student athletes.
- Employ advanced cardiac imaging in those with abnormal ECGs.
Disclosure Statement: Dr. McEldrew, faculty for this educational event has no relevant financial relationship(s) with ineligible companies to disclose.
Accreditation Statement: The Pennsylvania Osteopathic Medical Association (POMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. POMA designates this live activity for a maximum of 1.0 Category 1-A AOA CME credits and will report CME and specialty credits to the AOA commensurate with the extent of the physician’s participation in this activity.
Grievance Statement: If you are not satisfied with the program, you may file a written grievance by emailing cme@poma.org. Your complaint will be forwarded to the Education Committee for review. The committee will determine if the participant should be reimbursed with no credits or deny the complaint and take the issue into consideration for future programs.
McEldrewJamesHandout (2.5 MB) | Available after Purchase |
James McEldrew, DO, “Current Screening for High School and College Athletes, Including Sudden Death in Sports,” is an adult cardiovascular disease fellow at the Heart and Vascular Institute at Cooper University Hospital in Camden, New Jersey. A graduate of the University of Notre Dame (Ind.) and a 2019 graduate of the Philadelphia College of Osteopathic Medicine, he completed an internal medicine residency at Temple University Hospital in Philadelphia. He is a member of POMA, the American Osteopathic Association, the American College of Physicians, the European Society of Cardiology, the American Society of Echocardiography and the American Heart Association.
He has no relevant financial relationship(s) with ineligible companies to disclose.
Update in the Management of Congestive Heart Failure with Reduced Ejection Fraction in 2023
Original Program Date: 05/03/2023 |
Current Medical, Endovascular and Surgical Management of Carotid Artery Disease
Original Program Date: 05/03/2023 |
An Interdisciplinary Approach to Metabolic Disease Management with Cultural Considerations
Original Program Date: 05/04/2023 |